Skip to main content

AlphaLISA Human MMP-9 Detection Kit, 100 Assay Points

The AlphaLISA® Human Matrix Metalloproteinase-9 (MMP9) Detection Kit is designed for detection and quantitation of human MMP9 in serum, buffered solution or cell culture medium in a homogeneous (no-wash steps, no separation steps) assay. The kit was designed to detect both MMP9 and pro-MMP9.

This kit is a replaced for AL243.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Part Number: AL3138HV
Unit Size: 100 Assay Points
Part Number: AL3138F
Unit Size: 5,000 Assay Points
Part Number: AL3138C
Unit Size: 500 Assay Points
  • Formats:

    • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 μL reaction volume (5 μL of sample).
    • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 μL reaction volume (5 μL of sample).

    Features:

    • No-wash steps, no separation steps
    • ELISA alternative technology
    • Sensitive detection
    • Broad sample compatibility
    • Small sample volume
    • Results in less than 3 hours
    • Half the time of an ELISA assay

    Matrix Metalloproteinase-9 (MMP9) or gelatinase B is a 64-82 kDa, zinc- and calcium-dependent, endopeptidase secreted by normal alveolar macrophages and granulocytes. MMP9 is secreted as a pro-enzyme (pro-MMP9) and is activated by proteolytic cleavage by serine proteases including other MMPs. MMP9 is believed to act synergistically with MMP1 interstitial collagenase in the degradation of fibrillar collagens. MMP9 might contribute to the pathogenesis of joint destruction. MMP9 could also play a role in bone osteoclastic resorption and cancer metastasis. MMP9 constitutes a useful biomarker of disease status in arthritis and certain cancers.

    AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

  • Automation Compatible
    Yes
    Application
    Protein Analysis & Detection
    Assay Points
    100
    Assay Target
    MMP9
    Assay Target Class
    Phospho-protein
    Protein
    Assay Technology
    Alpha
    Detection Method
    Alpha
    Experimental Type
    In vitro
    Therapeutic Area
    Oncology
    Brand
    AlphaLISA
    Unit Size
    100 Assay Points